Stacy Ann Coen Immuno Gen, Inc. (IMGN) insider trading activity

IMGN Quotes by TradingView

Stacy Ann Coen is SVP & CHIEF BUSINESS OFFICER of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Feb 12, 2024, when has been sold 73,274 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Stacy Ann Coen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2024
SELL
Sale (or disposition) back to the issuer
-
73,274 Reduced 100.0%
0 Common Stock
Feb 05 2024
SELL
Open market or private sale
$134,281 $29.3 p/Share
4,583 Reduced 5.89%
73,274 Common Stock
Feb 02 2024
BUY
Exercise of conversion of derivative security
-
14,350 Added 15.56%
77,857 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$5,875 $16.01 p/Share
367 Added 0.57%
63,507 Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$159,600 $5.32 p/Share
30,000 Added 32.21%
63,140 Common Stock
Nov 30 2023
SELL
Open market or private sale
$111,719 $29.2 p/Share
3,826 Reduced 10.35%
33,140 Common Stock
Nov 17 2023
SELL
Open market or private sale
$1,255,479 $16.05 p/Share
78,223 Reduced 67.91%
36,966 Common Stock
Nov 17 2023
BUY
Exercise of conversion of derivative security
$493,587 $6.31 p/Share
78,223 Added 40.44%
115,189 Common Stock
Nov 16 2023
SELL
Open market or private sale
$65,641 $16.01 p/Share
4,100 Reduced 9.98%
36,966 Common Stock
Nov 16 2023
BUY
Exercise of conversion of derivative security
$25,871 $6.31 p/Share
4,100 Added 9.08%
41,066 Common Stock
Nov 15 2023
SELL
Open market or private sale
$420,838 $16.01 p/Share
26,286 Reduced 41.56%
36,966 Common Stock
Nov 15 2023
BUY
Exercise of conversion of derivative security
$165,864 $6.31 p/Share
26,286 Added 29.36%
63,252 Common Stock
Sep 08 2023
BUY
Exercise of conversion of derivative security
$199,986 $7.69 p/Share
26,006 Added 41.3%
36,966 Common Stock
Aug 09 2023
SELL
Open market or private sale
$1,422,982 $14.2 p/Share
100,210 Reduced 90.14%
10,960 Common Stock
Aug 09 2023
BUY
Exercise of conversion of derivative security
$493,033 $4.92 p/Share
100,210 Added 47.41%
111,170 Common Stock
Aug 04 2023
SELL
Open market or private sale
$1,369,558 $17.05 p/Share
80,326 Reduced 87.99%
10,960 Common Stock
Aug 04 2023
BUY
Exercise of conversion of derivative security
$395,203 $4.92 p/Share
80,326 Added 46.81%
91,286 Common Stock
Aug 02 2023
SELL
Open market or private sale
$77,100 $18.12 p/Share
4,255 Reduced 27.97%
10,960 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
$20,934 $4.92 p/Share
4,255 Added 21.85%
15,215 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$15,357 $4.05 p/Share
3,792 Added 25.7%
10,960 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$12,800 $3.83 p/Share
3,342 Added 31.8%
7,168 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$8,378 $5.6 p/Share
1,496 Added 28.11%
3,826 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$12,862 $5.52 p/Share
2,330 Added 50.0%
2,330 Common Stock

Also insider at

FBLG
FibroBiologics, Inc.
Director
SAC

Stacy Ann Coen

SVP & CHIEF BUSINESS OFFICER
Waltham, MA

Track Institutional and Insider Activities on IMGN

Follow ImmunoGen, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMGN shares.

Notify only if

Insider Trading

Get notified when an Immuno Gen, Inc. insider buys or sells IMGN shares.

Notify only if

News

Receive news related to ImmunoGen, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMGN